Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature

• Publication date

  2012-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature11309PMID 22885698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B cell receptor signaling in chronic lymphocytic leukemia.

  2013cited by this paper
• Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia

  2012cited by this paper
• The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

  2011cited by this paper
• B‐cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia

  2011cited by this paper
• B-cell receptor signaling in chronic lymphocytic leukemia.

  2011cited by this paper
• N-linked glycosylation selectively regulates autonomous precursor BCR function

  2010cited by this paper
• The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.

  2010cited by this paper
• Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

  2010cited by this paper
• Development of self-reactive germinal center B cells and plasma cells in autoimmune FcγRIIB-deficient mice

  2010cited by this paper
• Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.

  2009cited by this paper
• High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.

  2009cited by this paper
• Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.

  2009cited by this paper
• Autoinhibition and adapter function of Syk

  2009cited by this paper
• Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells.

  2008cited by this paper
• Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation

  2008cited by this paper
• The Ig‐α ITAM is required for efficient differentiation but not proliferation of pre‐B cells

  2007cited by this paper
• Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor.

  2007cited by this paper
• The Ig-alpha ITAM is required for efficient differentiation but not proliferation of pre-B cells.

  2007cited by this paper
• Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli

  2006cited by this paper
• B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.

  2006cited by this paper
• Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

  2006cited by this paper
• Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

  2006cited by this paper
• Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

  2005cited by this paper
• Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

  2004cited by this paper
• Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.

  2004cited by this paper
• LAT links the pre-BCR to calcium signaling.

  2003cited by this paper
• Predominant Autoantibody Production by Early Human B Cell Precursors

  2003cited by this paper
• Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

  2002cited by this paper
• Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination.

  1999cited by this paper
• Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia

  1989cited by this paper

• CaMKK2 Identifies Biologically Aggressive Chronic Lymphocytic Leukemia and Regulates Leukemic Survival and Nurse-Like Cell Support

  2026cites this paper
• Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia.

  2025cites this paper
• Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies

  2025cites this paper
• Therapeutic advances in chronic lymphocytic leukemia: A focus on molecular pathogenesis, targeted therapies, and supportive care.

  2025cites this paper
• Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia

  2025cites this paper
• Phosphoproteomic Analysis of Signaling Pathways in Lymphomas.

  2025cites this paper
• B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.

  2025cites this paper
• The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia

  2025cites this paper
• SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor

  2025cites this paper
• Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptor

  2025cites this paper
• Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1

  2025cites this paper
• Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clones

  2025influential citation
• Expression Cloning of Antibodies from Single Human B Cells.

  2025cites this paper
• Recombinant Production of B-Cell Receptor Fab Fragments from Chronic Lymphocytic Leukemia in Mammalian Cells for Structural and Biochemical Studies.

  2025cites this paper
• CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma

  2025cites this paper
• IGLV 3-21R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia

  2025cites this paper
• The cytoskeletal control of B cell receptor and integrin signaling in normal B cells and chronic lymphocytic leukemia

  2025cites this paper
• Chronic lymphocytic leukemia often arises by a multiclonal selection process

  2025cites this paper
• CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: from interconnected signalling pathways to therapeutic strategies.

  2024cites this paper
• B Cells With Complementary B Cell Receptors Can Kill Each Other

  2024cites this paper
• Targeting the B cell receptor signaling pathway in chronic lymphocytic leukemia.

  2024cites this paper
• JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL

  2024cites this paper
• A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors

  2024cites this paper
• The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands

  2024cites this paper
• Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL

  2024influential citation
• B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy

  2024cites this paper
• Towards a unifying model for B-cell receptor triggering

  2024cites this paper
• Transgenic αβ TCR tonic signaling is leukemogenic while strong stimulation is leukemia-suppressive

  2024cites this paper
• B cells expressing mutated IGHV1-69–encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection

  2024cites this paper
• Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs

  2024cites this paper
• Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia

  2024cites this paper
• New means and challenges in the targeting of BTK.

  2024cites this paper
• An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

  2024cites this paper
• TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer.

  2024cites this paper
• Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

  2024cites this paper
• The malignant transformation potential of the oncogene STYK1/NOK at early lymphocyte development in transgenic mice

  2024cites this paper
• B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia

  2024cites this paper
• Innovations and developments in chronic lymphocytic leukemia therapy

  2024cites this paper
• Molecular Profiling of Small Mature B Cell Lymphomas; New Insights on Diagnosis and Treatment

  2024cites this paper
• Persistent B-Cell Stimulation or B-Cell Repertoire Anomalies? The Dilemma of the Origin of CLL

  2024cites this paper
• Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia

  2024cites this paper
• The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review

  2024cites this paper
• Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia

  2024cites this paper
• Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia

  2023cites this paper
• N-Glycosylation of the Ig Receptors Shapes the Antigen Reactivity in Chronic Lymphocytic Leukemia Subset #201.

  2023cites this paper
• Functional consequences of inhibition of Bruton's tyrosine kinase by ibrutinib in chronic lymphocytic leukemia

  2023cites this paper
• In vivo activity of the dual SYK/FLT3 inhibitor TAK‐659 against pediatric acute lymphoblastic leukemia xenografts

  2023cites this paper
• Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

  2023cites this paper
• Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia

  2023cites this paper
• NF-kB and the CLL microenvironment

  2023cites this paper
• Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.

  2023cites this paper
• The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives

  2023cites this paper
• XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling

  2023cites this paper
• The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia

  2023cites this paper
• Richter syndrome: Novel insights into the biology of transformation.

  2023cites this paper
• Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy

  2023cites this paper
• Emerging Therapies in CLL in the Era of Precision Medicine

  2023influential citation
• Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression.

  2023cites this paper
• B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells

  2023cites this paper
• B cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.

  2023cites this paper
• Blocking Orai1 constitutive activity inhibits B-cell cancer migration and synergistically acts with drugs to reduce B-CLL cell survival

  2023cites this paper
• Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

  2023cites this paper
• Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?

  2023cites this paper
• ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV–unmutated chronic lymphocytic leukemia

  2023cites this paper
• Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia

  2023cites this paper
• Prehistory of chronic lymphocytic leukemia: clues from the B-cell receptor

  2023influential citation
• Physiological and Pathophysiological Roles of IgM Fc Receptor (FcµR) Isoforms

  2023cites this paper
• In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival

  2023cites this paper
• Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia

  2022cites this paper
• In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities.

  2022cites this paper
• Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression

  2022cites this paper
• Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry

  2022cites this paper
• Macrophage- and BCR- but not TLR-derived signals support the growth of CLL and Richter Syndrome murine models in vivo.

  2022cites this paper
• BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies

  2022cites this paper
• Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications

  2022cites this paper
• Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia

  2022cites this paper
• Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

  2022cites this paper
• Soluble Fc Receptor for IgM in Sera From Subsets of Patients With Chronic Lymphocytic Leukemia as Determined by a New Mouse Monoclonal Antibody

  2022cites this paper
• Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

  2022cites this paper
• Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells

  2022cites this paper
• SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.

  2022cites this paper
• Spatial organization and early signaling of the B-cell receptor in CLL

  2022cites this paper
• Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia

  2022cites this paper
• Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia

  2022cites this paper
• The Paracaspase MALT1 in Cancer

  2022influential citation
• Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay

  2022cites this paper
• B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia

  2022cites this paper
• The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

  2022cites this paper
• Functional testing to characterize and stratify PI3K inhibitor responses in chronic lymphocytic leukemia.

  2022cites this paper
• BTK Inhibitors in Chronic Lymphocytic Leukemia

  2021cites this paper
• Evaluation of vecabrutinib as a model for non-covalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.

  2021cites this paper
• High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis

  2021cites this paper
• Genetics of Chronic Lymphocytic Leukemia.

  2021cites this paper
• Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients

  2021cites this paper
• Immunomodulatory Drugs for the Treatment of B Cell Malignancies

  2021cites this paper
• Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

  2021cites this paper
• Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells

  2021cites this paper
• Resistance to Bruton's Tyrosine Kinase Inhibitors: The Achilles Heel of Their Success Story in Lymphoid Malignancies.

  2021cites this paper
• Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic Leukemia

  2021cites this paper
• The Biology of Chronic Lymphocytic Leukemia

  2021cites this paper